Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.
作者信息
Schultz K R, Devidas M, Bowman W P, Aledo A, Slayton W B, Sather H, Zheng H W, Davies S M, Gaynon P S, Trigg M, Rutledge R, Jorstad D, Carroll A J, Heerema N, Winick N, Borowitz M J, Hunger S P, Carroll W L, Camitta B
机构信息
Division of Hematology/Oncology/BMT, Department of Pediatrics, British Columbia's Children's Hospital, University of British Columbia, Vancouver, British Columbia, Canada.
Children's Oncology Group Statistics and Data Center, Department of Biostatistics, The University of Florida, Gainesville, FL, USA.
出版信息
Leukemia. 2014 Apr;28(4):964-7. doi: 10.1038/leu.2014.29. Epub 2014 Jan 17.
Abstract
摘要
相似文献
1
Philadelphia chromosome-negative very high-risk acute lymphoblastic leukemia in children and adolescents: results from Children's Oncology Group Study AALL0031.儿童和青少年费城染色体阴性的极高危急性淋巴细胞白血病：儿童肿瘤研究组AALL0031研究结果
Leukemia. 2014 Apr;28(4):964-7. doi: 10.1038/leu.2014.29. Epub 2014 Jan 17.
2
Allogeneic bone marrow transplantation in first remission rescues children with Philadelphia chromosome-positive acute lymphoblastic leukemia: Tokyo Children's Cancer Study Group (TCCSG) studies L89-12 and L92-13.首次缓解期进行异基因骨髓移植可挽救费城染色体阳性急性淋巴细胞白血病患儿：东京儿童癌症研究组（TCCSG）的L89 - 12和L92 - 13研究
Med Pediatr Oncol. 2001 Nov;37(5):426-31. doi: 10.1002/mpo.1225.
3
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.伊马替尼改善费城染色体阳性急性淋巴细胞白血病患者的早期无事件生存率：一项儿童肿瘤学组研究
J Clin Oncol. 2009 Nov 1;27(31):5175-81. doi: 10.1200/JCO.2008.21.2514. Epub 2009 Oct 5.
4
[Recent advances in oncology. Acute lymphoblastic leukemia in children].[肿瘤学的最新进展。儿童急性淋巴细胞白血病]
Arch Fr Pediatr. 1991 Nov;48(9):657-63.
5
Acute lymphoblastic leukemia.急性淋巴细胞白血病。
J Natl Compr Canc Netw. 2012 Jul 1;10(7):858-914. doi: 10.6004/jnccn.2012.0089.
6
Current treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病的当前治疗方法。
Haematologica. 2010 Jan;95(1):8-12. doi: 10.3324/haematol.2009.015974.
7
Bone marrow transplantation for Philadelphia-chromosome-positive acute lymphoblastic leukemia.
Bone Marrow Transplant. 1995 Nov;16(5):663-7.
8
Treatment of high-risk Philadelphia chromosome-negative acute lymphoblastic leukemia in adolescents and adults according to early cytologic response and minimal residual disease after consolidation assessed by flow cytometry: final results of the PETHEMA ALL-AR-03 trial.根据强化治疗后流式细胞术评估的早期细胞形态学反应和微小残留病对青少年和成人高危费城染色体阴性急性淋巴细胞白血病的治疗：PETHEMA ALL-AR-03 试验的最终结果。
J Clin Oncol. 2014 May 20;32(15):1595-604. doi: 10.1200/JCO.2013.52.2425. Epub 2014 Apr 21.
9
Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia.费城染色体阳性急性淋巴细胞白血病的治疗。
Leuk Lymphoma. 2009 Dec;50 Suppl 2:9-15. doi: 10.3109/10428190903370395.
10
引用本文的文献
1
FLT4 activation promotes acute lymphoid leukemia survival through stabilization of MDM2/MDMX and inactivation of p53.FLT4激活通过稳定MDM2/MDMX和使p53失活来促进急性淋巴细胞白血病的存活。
Oncogenesis. 2025 May 2;14(1):14. doi: 10.1038/s41389-025-00552-7.
2
Relapsed childhood T-cell acute lymphoblastic leukemia and lymphoblastic lymphoma.复发性儿童T细胞急性淋巴细胞白血病和淋巴细胞淋巴瘤。
Haematologica. 2025 Sep 1;110(9):1934-1950. doi: 10.3324/haematol.2024.285643. Epub 2025 Jan 9.
3
Acute Lymphoblastic Leukemia in a Patient With Advanced Breast Cancer Treated With Cyclin-Dependent Kinase 4/6 Inhibitors and Endocrine Therapy.一名晚期乳腺癌患者接受细胞周期蛋白依赖性激酶4/6抑制剂和内分泌治疗后发生急性淋巴细胞白血病。
Cureus. 2024 Sep 16;16(9):e69548. doi: 10.7759/cureus.69548. eCollection 2024 Sep.
4
Significance and implications of FHIT gene expression and promoter hypermethylation in acute lymphoblastic leukemia (ALL).FHIT基因表达及启动子高甲基化在急性淋巴细胞白血病（ALL）中的意义及影响
Discov Oncol. 2024 Apr 8;15(1):108. doi: 10.1007/s12672-024-00971-9.
5
Combination Early-Phase Trials of Anticancer Agents in Children and Adolescents.儿童和青少年抗癌药物的联合早期临床试验。
J Clin Oncol. 2023 Jun 20;41(18):3408-3422. doi: 10.1200/JCO.22.02430. Epub 2023 Apr 4.
6
Ethnic-specific predictors of neurotoxicity among patients with pediatric acute lymphoblastic leukemia after high-dose methotrexate.儿童急性淋巴细胞白血病患者接受大剂量甲氨蝶呤治疗后的神经毒性的种族特异性预测因素。
Cancer. 2023 Apr 15;129(8):1287-1294. doi: 10.1002/cncr.34646. Epub 2023 Jan 24.
7
Clinical and demographic factors contributing to asparaginase-associated toxicities in children with acute lymphoblastic leukemia.导致儿童急性淋巴细胞白血病患者 asparaginase 相关毒性的临床和人口统计学因素。
Leuk Lymphoma. 2022 Dec;63(12):2948-2954. doi: 10.1080/10428194.2022.2102621. Epub 2022 Jul 27.
8
Genetic Biomarkers and Their Clinical Implications in B-Cell Acute Lymphoblastic Leukemia in Children.儿童 B 细胞急性淋巴细胞白血病的遗传生物标志物及其临床意义。
Int J Mol Sci. 2022 Mar 2;23(5):2755. doi: 10.3390/ijms23052755.
9
Near-Haploidy and Low-Hypodiploidy in B-Cell Acute Lymphoblastic Leukemia: When Less Is Too Much.B细胞急性淋巴细胞白血病中的近单倍体和低亚二倍体：少亦为多之情形。
Cancers (Basel). 2021 Dec 22;14(1):32. doi: 10.3390/cancers14010032.
10
Genetic Alterations in Childhood Acute Lymphoblastic Leukemia: Interactions with Clinical Features and Treatment Response.儿童急性淋巴细胞白血病的基因改变：与临床特征及治疗反应的相互作用
Cancers (Basel). 2021 Aug 12;13(16):4068. doi: 10.3390/cancers13164068.
本文引用的文献
1
The genomic landscape of hypodiploid acute lymphoblastic leukemia.低倍体急性淋巴细胞白血病的基因组景观。
Nat Genet. 2013 Mar;45(3):242-52. doi: 10.1038/ng.2532. Epub 2013 Jan 20.
2
Outcomes after induction failure in childhood acute lymphoblastic leukemia.儿童急性淋巴细胞白血病诱导失败后的结局。
N Engl J Med. 2012 Apr 12;366(15):1371-81. doi: 10.1056/NEJMoa1110169.
3
Improved survival for children and adolescents with acute lymphoblastic leukemia between 1990 and 2005: a report from the children's oncology group.1990 至 2005 年期间儿童及青少年急性淋巴细胞白血病存活率的提高：儿童肿瘤协作组的报告。
J Clin Oncol. 2012 May 10;30(14):1663-9. doi: 10.1200/JCO.2011.37.8018. Epub 2012 Mar 12.
4
Hematopoietic stem-cell transplantation for acute leukemia in relapse or primary induction failure.造血干细胞移植治疗复发或初次诱导失败的急性白血病。
J Clin Oncol. 2010 Aug 10;28(23):3730-8. doi: 10.1200/JCO.2010.28.8852. Epub 2010 Jul 12.
5
Remission re-induction chemotherapy with clofarabine, topotecan, thiotepa, and vinorelbine for patients with relapsed or refractory leukemia.用克拉屈滨、拓扑替康、噻替派和长春瑞滨对复发或难治性白血病患者进行缓解后再诱导化疗。
Pediatr Blood Cancer. 2010 May;54(5):687-93. doi: 10.1002/pbc.22321.
6
Long-term results of the children's cancer group studies for childhood acute lymphoblastic leukemia 1983-2002: a Children's Oncology Group Report.1983-2002 年儿童癌症组研究儿童急性淋巴细胞白血病的长期结果：儿童肿瘤学组报告。
Leukemia. 2010 Feb;24(2):285-97. doi: 10.1038/leu.2009.262. Epub 2009 Dec 17.
7
Improved early event-free survival with imatinib in Philadelphia chromosome-positive acute lymphoblastic leukemia: a children's oncology group study.伊马替尼改善费城染色体阳性急性淋巴细胞白血病患者的早期无事件生存率：一项儿童肿瘤学组研究
J Clin Oncol. 2009 Nov 1;27(31):5175-81. doi: 10.1200/JCO.2008.21.2514. Epub 2009 Oct 5.
8
A multi-center phase I study of clofarabine, etoposide and cyclophosphamide in combination in pediatric patients with refractory or relapsed acute leukemia.一项关于克拉屈滨、依托泊苷和环磷酰胺联合治疗难治性或复发性急性白血病患儿的多中心 I 期研究。
Leukemia. 2009 Dec;23(12):2259-64. doi: 10.1038/leu.2009.185. Epub 2009 Sep 10.
9
Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia and its relationship to other prognostic factors: a Children's Oncology Group study.儿童急性淋巴细胞白血病微小残留病的临床意义及其与其他预后因素的关系：一项儿童肿瘤研究组的研究
Blood. 2008 Jun 15;111(12):5477-85. doi: 10.1182/blood-2008-01-132837. Epub 2008 Apr 3.
10
Outcome of treatment in children with hypodiploid acute lymphoblastic leukemia.低二倍体急性淋巴细胞白血病患儿的治疗结果
Blood. 2007 Aug 15;110(4):1112-5. doi: 10.1182/blood-2006-07-038299. Epub 2007 May 1.
Zotero 插件